Cargando…
PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
Epstein-Barr virus-positive gastric cancer [EBV (+) GC] is a distinct GC subtype with unique genetic and epigenetic aberrations. Here, we examined resected GC samples and publicly available microarray data and The Cancer Genome Atlas (TCGA) database to identify the mechanism underlying overexpressio...
Autores principales: | Nakano, Hiroshi, Saito, Motonobu, Nakajima, Shotaro, Saito, Katsuharu, Nakayama, Yuko, Kase, Koji, Yamada, Leo, Kanke, Yasuyuki, Hanayama, Hiroyuki, Onozawa, Hisashi, Okayama, Hirokazu, Fujita, Shotaro, Sakamoto, Wataru, Saze, Zenichiro, Momma, Tomoyuki, Mimura, Kosaku, Ohki, Shinji, Goto, Akiteru, Kono, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820576/ https://www.ncbi.nlm.nih.gov/pubmed/33479394 http://dx.doi.org/10.1038/s41598-021-81667-w |
Ejemplares similares
-
Tn Antigen Expression Defines an Immune Cold Subset of Mismatch-Repair Deficient Colorectal Cancer
por: Matsumoto, Takuro, et al.
Publicado: (2020) -
Short-term outcomes of neoadjuvant chemotherapy with capecitabine plus oxaliplatin for patients with locally advanced rectal cancer followed by total or tumor-specific mesorectal excision with or without lateral pelvic lymph node dissection
por: Sakamoto, Wataru, et al.
Publicado: (2022) -
A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ
por: Kikuchi, Tomohiro, et al.
Publicado: (2019) -
Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy
por: Sakamoto, Wataru, et al.
Publicado: (2021) -
Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma
por: Yamauchi, Naoto, et al.
Publicado: (2021)